Scioto Biosciences

Scioto Biosciences is a preclinical-stage company dedicated to developing innovative therapies and focusing on the research of microbiome-based treatments. Scioto Biosciences has developed a novel formulation that combines beneficial bacteria in the human body with polysaccharide microspheres, activating the biofilm formation mechanism of probiotics. These mechanisms induce the formation of "biofilms," enhancing the performance of probiotics and enabling non-spore-forming bacteria to survive through the gastrointestinal system, which serves as a preventive mechanism for NEC.